PACS Group, Inc.
Customers
2
2 active
Suppliers
1
0 active
Largest customer
39.3%
Medicaid · 3M to 2026-06-30
Named-customer revenue
$1.0B
2 customers · 3M to 2026-06-30
Latest period
Jun 30, 2026
10-Q filed 2026-08-04
Customers 2
Companies PACS discloses as major customers, as a share of PACS revenue. 2 active, 0 lapsed.
| Company | % of PACS revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Medicaid Non-SEC Medicaid |
39.3% | $561.0M | 3M 2026-06-30 | −0.7pp | Active | 10-Q 2026-08-04 |
Medicaid 561,050 39.3 % 524,578 40.1 % Medicaid 568,026 40.0 % 515,004 40.3 % A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively. Revenue from the Medicaid program amounted to 41.1% and 40.0% of the Company’s condensed consolidated net patient and resident revenue for the three months ended September 30, 2025 and 2024, respectively, and 40.5% and 39.8% of the Company’s condensed consolidated net patient and resident revenue for the nine months ended September 30, 2025 and 2024, respectively. Revenue from the Medicaid program amounted to 40.1% and 40.0% of the Company’s condensed consolidated net patient and resident revenue for the three months ended June 30, 2025 and 2024, respectively, and 40.2% and 39.7% of the Company’s condensed consolidated net patient and resident revenue for the six months ended June 30, 2025 and 2024, respectively. Revenue from the Medicaid program amounted to 40.3% and 39.4% of the Company’s condensed consolidated net patient and resident revenue for the three months ended March 31, 2025 and 2024, respectively. Revenue from the Medicaid program amounted to 40.0% and 42.3% of the Company’s condensed combined/consolidated net patient and resident revenue for the three months ended September 30, 2024 and 2023, respectively, and 39.8% and 36.2% of the Company’s condensed combined/consolidated net patient and resident revenue for the nine months ended September 30, 2024 and 2023, respectively. | ||||||
| Medicare Non-SEC Medicare |
34.2% | $488.2M | 3M 2026-06-30 | −0.3pp | Active | 10-Q 2026-08-04 |
Medicare $ 487,315 34.2 % $ 452,507 34.6 % Medicare $ 489,636 34.5 % $ 443,476 34.7 % A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively. Revenue from the Medicare program amounted to 32.7% and 34.4% of the Company’s condensed consolidated net patient and resident revenue for the three months ended September 30, 2025 and 2024, respectively, and 34.0% and 34.5% of the Company’s condensed consolidated net patient and resident revenue for the nine months ended September 30, 2025 and 2024, respectively. Revenue from the Medicare program amounted to 34.6% and 34.4% of the Company’s condensed consolidated net patient and resident revenue for the three months ended June 30, 2025 and 2024, respectively, and 34.6% and 34.5% of the Company’s condensed consolidated net patient and resident revenue for the six months ended June 30, 2025 and 2024, respectively. Revenue from the Medicare program amounted to 34.7% and 34.6% of the Company’s condensed consolidated net patient and resident revenue for the three months ended March 31, 2025 and 2024, respectively. Revenue from the Medicare program amounted to 34.4% and 32.8% of the Company’s condensed combined/consolidated net patient and resident revenue for the three months ended September 30, 2024 and 2023, respectively, and 34.5% and 40.6% of the Company’s condensed combined/consolidated net patient and resident revenue for the nine months ended September 30, 2024 and 2023, respectively. | ||||||
Suppliers 1
Companies that disclose PACS as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from PACS | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| CTRE CareTrust REIT, Inc. |
10% | — | 3M 2025-06-30 | −1.0pp | Lapsed Last seen 2025-06-30 |
10-Q 2026-08-06 |
PACS (2) 10 % 10 % PACS (2) 11 % | ||||||
Alerts are coming
Get an email when PACS's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.